ID_sample	localisation	Gene	Ensembl_ID	type_alt	seq_ref	seq_alt	seq_before_mut	seq_mut	seq_after_mut	kmer_ref	kmer_alt	count_ref	count_alt	%ratio
BA2088R-BM	Chr13:32398243	BRCA2	ENST00000380152	Mutation 	G	A	GGAAGTCTGTTTCCACACCT	A	TCTCAGCCCAGATGACTTCA	GGAAGTCTGTTTCCACACCTGTCTCAGCCCAGATGACTTCA	GGAAGTCTGTTTCCACACCTATCTCAGCCCAGATGACTTCA	54	65	54.62%
BA2088R-BM	Chr13:32355172	BRCA2	ENST00000380152	Mutation 	A	G	AAAGCAAAACATTGATGGAC	G	TGGCTCTGATGATAGTAAAA	AAAGCAAAACATTGATGGACATGGCTCTGATGATAGTAAAA	AAAGCAAAACATTGATGGACGTGGCTCTGATGATAGTAAAA	10	38	79.17%
BA2088R-BM	Chr13:32339773	BRCA2	ENST00000380152	Mutation 	A	G	TACCCACAAACTGTAAATGA	G	GATATTTGCGTTGAGGAACT	TACCCACAAACTGTAAATGAAGATATTTGCGTTGAGGAACT	TACCCACAAACTGTAAATGAGGATATTTGCGTTGAGGAACT	35	26	42.62%
BA2088R-BM	Chr13:32332674	BRCA2	ENST00000380152	Mutation 	G	C	GTACCCTTTCGCACAACTAA	C	GAACGTCAAGAGATACAGAA	GTACCCTTTCGCACAACTAAGGAACGTCAAGAGATACAGAA	GTACCCTTTCGCACAACTAACGAACGTCAAGAGATACAGAA	17	21	55.26%
BA3202	Chr13:32398243	BRCA2	ENST00000380152	Mutation 	G	A	GGAAGTCTGTTTCCACACCT	A	TCTCAGCCCAGATGACTTCA	GGAAGTCTGTTTCCACACCTGTCTCAGCCCAGATGACTTCA	GGAAGTCTGTTTCCACACCTATCTCAGCCCAGATGACTTCA	28	33	54.1%
BA3202	Chr13:32355172	BRCA2	ENST00000380152	Mutation 	A	G	AAAGCAAAACATTGATGGAC	G	TGGCTCTGATGATAGTAAAA	AAAGCAAAACATTGATGGACATGGCTCTGATGATAGTAAAA	AAAGCAAAACATTGATGGACGTGGCTCTGATGATAGTAAAA	11	19	63.33%
BA3202	Chr13:32339773	BRCA2	ENST00000380152	Mutation 	A	G	TACCCACAAACTGTAAATGA	G	GATATTTGCGTTGAGGAACT	TACCCACAAACTGTAAATGAAGATATTTGCGTTGAGGAACT	TACCCACAAACTGTAAATGAGGATATTTGCGTTGAGGAACT	23	12	34.29%
BA3202	Chr13:32332674	BRCA2	ENST00000380152	Mutation 	G	C	GTACCCTTTCGCACAACTAA	C	GAACGTCAAGAGATACAGAA	GTACCCTTTCGCACAACTAAGGAACGTCAAGAGATACAGAA	GTACCCTTTCGCACAACTAACGAACGTCAAGAGATACAGAA	15	17	53.12%
BA2089R-PBMC	Chr13:32319289	BRCA2	ENST00000380152	Mutation 	C	T	CTCTGCCGCTGTACCAATCT	T	CTGTAAAAGAATTAGATAAA	CTCTGCCGCTGTACCAATCTCCTGTAAAAGAATTAGATAAA	CTCTGCCGCTGTACCAATCTTCTGTAAAAGAATTAGATAAA	0	12	100.0%
BA2218R-PBMC	Chr13:32346841	BRCA2	ENST00000380152	Mutation 	C	T	CAGATGGCACAATAAAAGAT	T	GAAGATTGTTTATGCATCAT	CAGATGGCACAATAAAAGATCGAAGATTGTTTATGCATCAT	CAGATGGCACAATAAAAGATTGAAGATTGTTTATGCATCAT	0	18	100.0%
BA2355R-BM	Chr13:32346834	BRCA2	ENST00000380152	Mutation 	A	G	AGCACTCCAGATGGCACAAT	G	AAAGATCGAAGATTGTTTAT	AGCACTCCAGATGGCACAATAAAAGATCGAAGATTGTTTAT	AGCACTCCAGATGGCACAATGAAAGATCGAAGATTGTTTAT	0	14	100.0%
BA2492R-BM	Chr13:32398233	BRCA2	ENST00000380152	Mutation 	T	C	ATGGCCAAAAGGAAGTCTGT	C	TCCACACCTGTCTCAGCCCA	ATGGCCAAAAGGAAGTCTGTTTCCACACCTGTCTCAGCCCA	ATGGCCAAAAGGAAGTCTGTCTCCACACCTGTCTCAGCCCA	29	25	46.3%
BA2723R-PBMC	Chr13:32398233	BRCA2	ENST00000380152	Mutation 	T	C	ATGGCCAAAAGGAAGTCTGT	C	TCCACACCTGTCTCAGCCCA	ATGGCCAAAAGGAAGTCTGTTTCCACACCTGTCTCAGCCCA	ATGGCCAAAAGGAAGTCTGTCTCCACACCTGTCTCAGCCCA	24	34	58.62%
BA2500R-BM	Chr13:32394797	BRCA2	ENST00000380152	Mutation 	C	T	GCCTCATATGTTAATTGCTG	T	AAGCAACCTCCAGTGGCGAC	GCCTCATATGTTAATTGCTGCAAGCAACCTCCAGTGGCGAC	GCCTCATATGTTAATTGCTGTAAGCAACCTCCAGTGGCGAC	28	36	56.25%
BA2501R-PBMC	Chr13:32337871	BRCA2	ENST00000380152	Mutation 	G	A	GTCATAATGAATGCCCCATC	A	ATTGGTCAGGTAGACAGCAG	GTCATAATGAATGCCCCATCGATTGGTCAGGTAGACAGCAG	GTCATAATGAATGCCCCATCAATTGGTCAGGTAGACAGCAG	6	7	53.85%
BA2501R-PBMC	Chr13:32371035	BRCA2	ENST00000380152	Mutation 	A	C	GGAAGCAGCAAAATATGTGG	C	GGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGAGGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGCGGCCCAACAAAAGAGACTAG	9	7	43.75%
BA2733R-PBMC	Chr13:32371035	BRCA2	ENST00000380152	Mutation 	A	C	GGAAGCAGCAAAATATGTGG	C	GGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGAGGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGCGGCCCAACAAAAGAGACTAG	4	7	63.64%
BA3242	Chr13:32371035	BRCA2	ENST00000380152	Mutation 	A	C	GGAAGCAGCAAAATATGTGG	C	GGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGAGGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGCGGCCCAACAAAAGAGACTAG	3	17	85.0%
BA3270	Chr13:32371035	BRCA2	ENST00000380152	Mutation 	A	C	GGAAGCAGCAAAATATGTGG	C	GGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGAGGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGCGGCCCAACAAAAGAGACTAG	9	17	65.38%
BA3302	Chr13:32371035	BRCA2	ENST00000380152	Mutation 	A	C	GGAAGCAGCAAAATATGTGG	C	GGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGAGGCCCAACAAAAGAGACTAG	GGAAGCAGCAAAATATGTGGCGGCCCAACAAAAGAGACTAG	35	26	42.62%
BA2655R-BM	Chr13:32376769	BRCA2	ENST00000380152	Mutation 	C	G	TTATGAAGCAGTGAAGAATG	G	AGCAGACCCAGCTTACCTTG	TTATGAAGCAGTGAAGAATGCAGCAGACCCAGCTTACCTTG	TTATGAAGCAGTGAAGAATGGAGCAGACCCAGCTTACCTTG	22	18	45.0%
BA3178	Chr13:32363384	BRCA2	ENST00000380152	Mutation 	G	A	TTACAGATGGGTGGTATGCT	A	TTAAGGCCCAGTTAGATCCT	TTACAGATGGGTGGTATGCTGTTAAGGCCCAGTTAGATCCT	TTACAGATGGGTGGTATGCTATTAAGGCCCAGTTAGATCCT	5	7	58.33%
BA3255	Chr13:32363384	BRCA2	ENST00000380152	Mutation 	G	A	TTACAGATGGGTGGTATGCT	A	TTAAGGCCCAGTTAGATCCT	TTACAGATGGGTGGTATGCTGTTAAGGCCCAGTTAGATCCT	TTACAGATGGGTGGTATGCTATTAAGGCCCAGTTAGATCCT	2	18	90.0%
BA2685R-BM	Chr13:32398489	BRCA2	ENST00000380152	Mutation 	A	T	CTCCTCAGATGACTCCATTT	T	AAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTAAAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTTAAAAATTCAATGAAATTTCT	16	14	46.67%
BA2914R-BM	Chr13:32398489	BRCA2	ENST00000380152	Mutation 	A	T	CTCCTCAGATGACTCCATTT	T	AAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTAAAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTTAAAAATTCAATGAAATTTCT	10	11	52.38%
BA2926R-BM	Chr13:32398489	BRCA2	ENST00000380152	Mutation 	A	T	CTCCTCAGATGACTCCATTT	T	AAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTAAAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTTAAAAATTCAATGAAATTTCT	0	11	100.0%
BA2962R-BM	Chr13:32398489	BRCA2	ENST00000380152	Mutation 	A	T	CTCCTCAGATGACTCCATTT	T	AAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTAAAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTTAAAAATTCAATGAAATTTCT	6	8	57.14%
BA3189	Chr13:32398489	BRCA2	ENST00000380152	Mutation 	A	T	CTCCTCAGATGACTCCATTT	T	AAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTAAAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTTAAAAATTCAATGAAATTTCT	9	10	52.63%
BA3199	Chr13:32398489	BRCA2	ENST00000380152	Mutation 	A	T	CTCCTCAGATGACTCCATTT	T	AAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTAAAAAATTCAATGAAATTTCT	CTCCTCAGATGACTCCATTTTAAAAATTCAATGAAATTTCT	24	18	42.86%
